Saturday, October 20th, 10:00 - 16:30
The conference is open to everyone and will be held at the BRFAA auditorium
There is no entrance fee
The official language is Greek, except for the talks of the two invited speakers which will be given in English.
PROGRAM
1st Session |
“Basic research in Greece on pancreatic β-cells” |
G.Chroussos |
10:00-10:30 | Pancreatic beta cells generation and regeneration: challenges ahead | A.Gavalas |
10:30-11:00 | Survival pathways in insulin-producing pancreatic β- cells | E.Tsilibari |
11:00-11:30 | The role of ERp46, an endoplasmic reticulum component, on the function of beta cells | A.Charonis |
11:30-12:00 | Coffee break | |
2nd Session |
“GLP1 and Current Treatment Needs” |
G.Dimitriadis |
12:00-13:00 | Development of a GLP1 analogue | L.Knudsen |
13:00-13:30 | Unmet Needs in Current Diabetic Treatment | A.Melidonis |
13:30-14:00 | Redefining the therapeutic targets in diabetes, with a GLP1 analogue | I.Ioannidis |
14:00-14:15 | Coffee break | |
3rd Session |
“Liraglutide and Cardiovascular Effects” |
D.Kokkinos – M.Benroubi |
14:15-15:15 | Presentation of the LEADER® study | S.Jacob |
15:15-16:30 | Lunch |